Sort by
Refine Your Search
-
Listed
-
Category
-
Country
- United States
- United Kingdom
- Germany
- France
- Sweden
- Portugal
- Spain
- Belgium
- Poland
- Netherlands
- Norway
- Denmark
- Singapore
- Canada
- Czech
- Italy
- Switzerland
- Ireland
- Finland
- Austria
- Hong Kong
- Australia
- Luxembourg
- Japan
- China
- Romania
- Brazil
- Croatia
- Greece
- United Arab Emirates
- Lithuania
- Mexico
- Morocco
- Saudi Arabia
- India
- Macau
- Worldwide
- Latvia
- Andorra
- Bulgaria
- Estonia
- Iceland
- Israel
- Malta
- New Zealand
- Slovakia
- South Korea
- Taiwan
- 38 more »
- « less
-
Program
-
Field
-
the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description PhD position in Translational Cell Biology (f/m
-
sequencing methods including DNA-sequencing, RNA-sequencing (RNA-seq), ATAC-seq, ChIP-seq, CUT&RUN, CUT&TAG, single-cell ATAC+RNA-seq, among other approaches), analysis of functional screening datasets (i.e
-
Technologist B/C (Pathology Bioresource) Job Profile Title Resource Technologist B Job Description Summary The Resource Technologist B/C will provide high quality cell sorting and analytical services
-
of the tasks that will be carried out are: Cell culture, RNA extraction, and qRT-PCR Western blotting, immunoperoxidase stains, and immunofluorescence Experimental work with animals, genotyping
-
, earth or energy. Learn more at www.hds-lee.de . Institute specific promise here. We are looking to recruit a PhD position – Co-regulation structures for large-scale single-cell transcriptomics – within
-
Lab aims to reveal how metabolism, oxidative stress, and cell death converge to shape cell fate. For more information about the Henry Lab, please visit: https://thehenrylab.squarespace.com/ For more
-
Medicine (https://www.irem.uzh.ch/en.html) combines cutting-edge stem cell and bioengineering research to advance regenerative therapies. Based on bio-inspired principles and novel biomimetic technologies
-
primarily focuses on studying aging and diseases of the central nervous system using stem cell, reprogramming, and genome‑modifying technologies. The research group works on several projects related
-
(Nature 2017; Nature Biotechnology 2020; Cell 2020), which we applied to gain mechanistic insights into disease (Nature Medicine 2018; Nature Medicine 2020). Our ultimate goal is to identify novel and
-
to traverse genes and complete transcription, as well as those that abort this process by removing or destroying Pol II on genes e.g. https://doi.org/10.64898/2025.12.04.692291 ; https://doi.org/10.1016